Guardant Health
GH
#2453
Rank
A$8.70 B
Marketcap
$70.50
Share price
-0.46%
Change (1 day)
177.02%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -$7.37

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -$7.70. In 2022 the company made an earnings per share (EPS) of -$10.03 a decrease over its 2021 EPS that were of -$6.27.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.37-26.53%
2022-$10.0360%
2021-$6.2755.04%
2020-$4.04207.14%
2019-$1.32-19.81%
2018-$1.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$7.56-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.19-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA